Waltham biotech raises $336M for new Covid-19 drug

Alongside mainstream vaccine developers such as Pfizer-BioNTech and Moderna Inc., a local biotech has made progress in coronavirus vaccines and treatments of its own — and plans to use its latest fundraise to advance its lead drug, which is being developed to work both as treatment and prevention therapy. Read More

Read More

Shareholder groups urge ‘no’ vote on GE exec pay

In August, GE changed Culp’s pay package in order to keep him at the helm of the company for longer. In so doing, it significantly lowered the target share prices that trigger awards for Culp, a reflection of the hit to the market caused by Covid-19, according to GE. Read More

Read More

Relay Therapeutics acquires AI startup for $85M

Relay Therapeutics, the Cambridge precision medicine company that raced onto the stock market last summer with one of the largest IPOs in the biotech industry, is looking to build out its data science capabilities. Read More

Read More